Clinical Trial Update: A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating toripalimab in combination with cisplatin and gemcitabine for recurrent/metastatic nasopharyngeal cancer, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Nasopharyngeal Cancer Recurrent | Phase 4 | Status: RECRUITING